"NZOZ Dom Sue Ryder prowadzony przez Pallmed sp. z o.o. jest wielospecjalistyczną placówką, która służy dorosłym i dzieciom wymagającym opieki paliatywnej i hospicyjnej. W Centrum Psychoneurologii Wieku Podeszłego zajmujemy się pacjentami, na każdym etapie choroby, począwszy od wczesnej diagnostyki, leczenia, opieki psychologicznej po terapię zajęciową i rehabilitację. Specjalistyczne zespoły medyczne zajmują się również chorymi wymagającymi żywienia dojelitowego oraz wentylacji mechanicznej przy pomocy respiratora. Co roku tysiące chorych z całej Polski mają szeroki dostęp do profesjonalnej opieki medycznej finansowanej przez Narodowy Fundusz Zdrowia."

During the past decade, NZOZ Dom Sue Ryder - Pallmed Sp. z o.o. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NZOZ Dom Sue Ryder - Pallmed Sp. z o.o." #1 sponsor was "AstraZeneca" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "H. Lundbeck A/S" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NZOZ Dom Sue Ryder - Pallmed Sp. z o.o." #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "ICON plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "NZOZ Dom Sue Ryder - Pallmed Sp. z o.o." are "Alzheimer's Disease" (3 trials), "Alzheimer Disease" (2 trials), "Alzheimer´s Disease" (1 trials), "Dementia" (1 trials) and "Major Depressive Disorder" (1 trials). Many other conditions were trialed in "NZOZ Dom Sue Ryder - Pallmed Sp. z o.o." in a lesser frequency.

Most popular intervention types in "NZOZ Dom Sue Ryder - Pallmed Sp. z o.o." are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Lanabecestat" (2 trials), "bapineuzumab" (2 trials), "placebo" (2 trials) and "Gantenerumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "NZOZ Dom Sue Ryder - Pallmed Sp. z o.o." are 7 trials for "All" genders.

Currently, there are NaN active trials in "NZOZ Dom Sue Ryder - Pallmed Sp. z o.o.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in NZOZ Dom Sue Ryder - Pallmed Sp. z o.o., undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in NZOZ Dom Sue Ryder - Pallmed Sp. z o.o., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".